Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
Clinical trial NCT01711554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01711554
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-04
- Primary completion
- 2018-09-14
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.